16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Machine Learning-Based Shear Wave Elastography Elastic Index (SWEEI) in Predicting Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma: A Comparative Analysis of Five Practical Prediction Models

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          Although many factors determine the prognosis of papillary thyroid carcinoma (PTC), cervical lymph node metastasis (CLNM) is one of the most terrible factors. In view of this, this study aimed to build a CLNM prediction model for papillary thyroid microcarcinoma (PTMC) with the help of machine learning algorithm.

          Methods

          We retrospectively analyzed 387 PTMC patients hospitalized in the Department of Medical Oncology, Enshi Tujia and Miao Autonomous Prefecture Central Hospital from January 1, 2015, to January 31, 2022. Based on supervised learning algorithms, namely random forest classifier (RFC), artificial neural network(ANN), support vector machine(SVM), decision tree(DT), and extreme gradient boosting gradient(XGboost) algorithm, the LNM prediction model was constructed, and the prediction efficiency of ML-based model was evaluated via receiver operating characteristic curve(ROC) and decision curve analysis(DCA).

          Results

          Finally, a total of 24 baseline variables were included in the supervised learning algorithm. According to the iterative analysis results, the pulsatility index(PI), resistance index(RI), peak systolic blood flow velocity(PSBV), systolic acceleration time(SAT), and shear wave elastography elastic index(SWEEI), such as average value(Emean), maximum value(Emax), and minimum value(Emix) were candidate predictors. Among the five supervised learning models, RFC had the strongest prediction efficiency with area under curve(AUC) of 0.889 (95% CI: 0.838–0.940) and 0.878 (95% CI: 0.821–0.935) in the training set and testing set, respectively. While ANN, DT, SVM and XGboost had prediction efficiency between 0.767 (95% CI: 0.716–0.818) and 0.854 (95% CI: 0.803–0.905) in the training set, and ranged from 0.762 (95% CI: 0.705–0.819) to 0.861 (95% CI: 0.804–0.918) in the testing set.

          Conclusion

          We have successfully constructed an ML-based prediction model, which can accurately classify the LNM risk of patients with PTMC. In particular, the RFC model can help tailor clinical decisions of treatment and surveillance.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

          Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Since the American Thyroid Association's (ATA's) guidelines for the management of these disorders were revised in 2009, significant scientific advances have occurred in the field. The aim of these guidelines is to inform clinicians, patients, researchers, and health policy makers on published evidence relating to the diagnosis and management of thyroid nodules and differentiated thyroid cancer.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Machine Learning in Medicine.

            Rahul Deo (2015)
            Spurred by advances in processing power, memory, storage, and an unprecedented wealth of data, computers are being asked to tackle increasingly complex learning tasks, often with astonishing success. Computers have now mastered a popular variant of poker, learned the laws of physics from experimental data, and become experts in video games - tasks that would have been deemed impossible not too long ago. In parallel, the number of companies centered on applying complex data analysis to varying industries has exploded, and it is thus unsurprising that some analytic companies are turning attention to problems in health care. The purpose of this review is to explore what problems in medicine might benefit from such learning approaches and use examples from the literature to introduce basic concepts in machine learning. It is important to note that seemingly large enough medical data sets and adequate learning algorithms have been available for many decades, and yet, although there are thousands of papers applying machine learning algorithms to medical data, very few have contributed meaningfully to clinical care. This lack of impact stands in stark contrast to the enormous relevance of machine learning to many other industries. Thus, part of my effort will be to identify what obstacles there may be to changing the practice of medicine through statistical learning approaches, and discuss how these might be overcome.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Thyroid cancer

              Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new cases occurred in men and women in 2015. The incidence continues to rise worldwide. Differentiated thyroid cancer is the most frequent subtype of thyroid cancer and in most patients the standard treatment (surgery followed by either radioactive iodine or observation) is effective. Patients with other, more rare subtypes of thyroid cancer-medullary and anaplastic-are ideally treated by physicians with experience managing these malignancies. Targeted treatments that are approved for differentiated and medullary thyroid cancers have prolonged progression-free survival, but these drugs are not curative and therefore are reserved for patients with progressive or symptomatic disease.
                Bookmark

                Author and article information

                Journal
                Cancer Manag Res
                Cancer Manag Res
                cmar
                Cancer Management and Research
                Dove
                1179-1322
                21 September 2022
                2022
                : 14
                : 2847-2858
                Affiliations
                [1 ]Department of Medical Oncology, Enshi Tujia and Miao Autonomous Prefecture Central Hospital , Enshi, 445000, People’s Republic of China
                [2 ]Department of Pediatric Surgery, Enshi Tujia and Miao Autonomous Prefecture Central Hospital , Enshi, 445000, People’s Republic of China
                Author notes
                Correspondence: Tao Zhang, Department of Pediatric Surgery, Enshi Tujia and Miao Autonomous Prefecture Central Hospital , No. 158 Wuyang Avenue, Enshi, People’s Republic of China, Email taozhang870214@163.com
                Huilin Mao, Enshi Tujia, and Miao Autonomous Prefecture , Enshi, Hubei Province, 445000, People’s Republic of China, Email maohuilin2022@163.com
                [*]

                These authors contributed equally to this work

                Article
                383152
                10.2147/CMAR.S383152
                9512413
                6f023a18-60aa-4f2a-a569-1fe0fde67ac4
                © 2022 Huang et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 21 July 2022
                : 14 September 2022
                Page count
                Figures: 5, Tables: 2, References: 40, Pages: 12
                Funding
                Funded by: Hubei Provincial Health Commission;
                The research was supported by the scientific research project of Hubei Provincial Health Commission (No.WJ2021Q019).
                Categories
                Original Research

                Oncology & Radiotherapy
                papillary thyroid microcarcinoma,cervical lymph node metastasis,shear wave elastography elastic index,machine learning algorithm,prediction model

                Comments

                Comment on this article